Nirma to buy majority stake in Glenmark Life Sciences
Glenmark Pharmaceuticals will sell 75% stake in its subsidiary Glenmark Life Sciences to Nirma Limited, for Rs 5652 crore, at ...
Glenmark Pharmaceuticals will sell 75% stake in its subsidiary Glenmark Life Sciences to Nirma Limited, for Rs 5652 crore, at ...
Mumbai: The Nirma Group is the frontrunner to acquire Glenmark Life Sciences (GLS), an 82.84% subsidiary of Glenmark Pharmaceuticals. The ...
Indian conglomerate Nirma Ltd. and PAG-backed Sekhmet Pharmaventures are among the shortlisted bidders for a controlling stake in Glenmark Life ...
Sekhmet Pharmaventures is competing with Ahmedabad-based Nirma Group to acquire Glenmark Life Sciences (GLS), an 82.85% subsidiary of Glenmark Pharmaceuticals ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.